![](https://endpts.com/wp-content/uploads/2021/04/Alan-List-Precision-tile-AP-scaled.jpg)
Precision CMO Alan List (Diane Bondareff/AP Images for Moffitt Cancer Center)
ASH: Another 'off-the-shelf' cell therapy leader shows durability issues, raising renewed concerns about emerging field
The next generation of cell therapies have focused in large part on the development of allogeneic — better known as “off-the-shelf — drugs that can cut manufacturing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.